Your best medicine news resource
Jul 16th 2008Drug InformationBreast Cancer
Patients with a rare type of breast cancer may benefit from receiving radiation therapy in addition to surgery to prevent recurrence, according to a study in the July issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, announced it has received approval from the China State Food and Drug Administration to market ABRAXANEŽ Paclitaxel for Injection (Albumin Bound) for the treatment of breast cancer after failure of standard chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. The Phase III clinical trials in the U.S.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor’s growth and spread, according to a new study from the University of Michigan Comprehensive Cancer Center. The gene, HER2, causes cancer stem cells to multiply and spread, explaining why HER2 has been linked to a more aggressive type of breast cancer and to metastatic disease, in which the cancer has spread beyond the breast, the researchers say.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
A new study in the Journal of Communication reveals that access to an integrated system of internet health resources helps patients more than simply providing a list of URLs to accredited sites. Breast cancer affects one in eight women and is the second leading cause of cancer death among women. Led by David H.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
The AuroraŽ Breast MRI Society, a rapidly growing group of dedicated breast health specialists committed to advancing the use of cutting-edge dedicated breast MRI technology, debuted its inaugural issue of The Journal of Breast MRI. The Journal was produced as a platform for Society members to relay clinical information and best practices for the detection, diagnosis and management of breast disease.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
The US Food and Drug Administration (FDA) announced on Tuesday that it had approved a new test that measures the strength of HER2 gene amplification in breast cancer patients so that decisions can be made about whether they should be given the cancer drug Herceptin (trastuzumab).
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
Although annual breast cancer screenings are recommended for most women ages 40 and older, physicians debate the value of regular mammograms for elderly women, who are more likely to die from unrelated causes, the New York Times reports.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
Recently identified genetic markers, called single nucleotide polymorphisms (SNPs), that are associated with a small but statistically significant increase in the risk of breast cancer do not appear to substantially improve the accuracy of existing models that use clinical factors to predict an individual’s risk, according to a study in the July 8 online issue of the Journal of the National Cancer Institute.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
Most women with breast cancer assume that surgery to preserve their breast will be less disfiguring than a mastectomy that removes the entire breast. But nearly one-third of women reported pronounced asymmetry between their breasts, and that perceived disfigurement greatly affects a woman’s quality of life after treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
More: continued here
Jul 16th 2008Drug InformationBreast Cancer
It is a staple of women’s health advice and visits to the OB/GYN: the monthly breast self-exam to check for lumps or other changes that might signal breast cancer. However, a review of recent studies says there is no evidence that self-exams actually reduce breast cancer deaths.
More: continued here
Your best medicine news resource
